As of November 6, 2026, Resmed Inc. is a publicly traded company (NYSE: RMD); its largest reported holder is Vanguard, with 8.21% on Schedule 13G of April 29, 2026, then AustralianSuper Pty Ltd (5.7%). The largest insider holding is Michael J. Farrell, the chairman and chief executive, with 481,893 shares (0.34% of shares outstanding), per Form 4 of October 8, 2026 (Schedule 13G, April 29, 2026).
Is this your company?
About to sign with, pay or invest in Resmed Inc.? See the free Snapshot first.
Free to see. No signup.
Is Resmed Inc. a real, registered company?
- Resmed Inc files with the SEC under CIK 943819 (its SEC filings).
- Its shares are listed under the ticker RMD on NYSE (also RSMDF) (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under RESMED INC in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Ronald Taylor, Director (Form 8-K filed 2026-08-17). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names AustralianSuper Pty Ltd (filed 2026-08-07).
Who are Resmed Inc.'s owners and officers?
Resmed Inc.: incorporated in Delaware; business address in San Diego, California; industry Surgical & Medical Instruments & Apparatus (Form D, 2026-08-17).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-07 | Australiansuper Pty LTD | 5.7% |
| Schedule 13G, 2026-04-29 | Vanguard Portfolio Management | 5.41% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 8.21% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-10-30 | The Vanguard Group | 13.66% |
Questions about who owns Resmed Inc.
Who owns Resmed Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Resmed Inc.: Vanguard Capital Management (8.21%, Schedule 13G, filed 2026-04-29), Australiansuper Pty LTD (5.7%, Schedule 13G, filed 2026-08-07) and Vanguard Portfolio Management (5.41%, Schedule 13G, filed 2026-04-29).
Who are the largest shareholders of Resmed Inc.?
By the share each holder's latest filing reports, the largest holders of Resmed Inc. on this page are Vanguard Capital Management (8.21%), Australiansuper Pty LTD (5.7%) and Vanguard Portfolio Management (5.41%).
When did Vanguard Capital Management buy into Resmed Inc.?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Capital Management on this page is the Schedule 13G, filed 2026-04-29, reporting 8.21%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Resmed Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Resmed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Resmed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-17 | Ronald Taylor | Director | departed | |
| Form 8-K, 2026-04-30 | Brett Sandercock | Chief Financial Officer | departed | |
| Form 8-K, 2026-04-30 | Aaron Bloomer | Chief Financial Officer | appointed | 2026-05-04 |
| Form 8-K, 2026-04-30 | Aaron Bloomer | Principal Financial Officer | appointed |
Which insiders own Resmed Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chairman and chief executive: 481,893 shares (0.34% of shares outstanding), 479,803 held directly and 2,090 indirectly (Form 4, 2026-10-08).
- , the chief financial officer: 83,495 shares (0.06% of shares outstanding) (Form 4, 2026-05-04).
- , a director: 51,803 shares (0.04% of shares outstanding) (Form 4, 2026-09-04).
- , the chief product officer: 35,489 shares (0.03% of shares outstanding) (Form 4, 2026-10-01).
- , a director: 24,771 shares (0.02% of shares outstanding) (Form 4, 2025-11-24).
Shares outstanding: 140,657,071 as of 2026-10-26, from the company's latest SEC cover page.
How much has Resmed Inc. raised?
No fundraising or offering filing from Resmed Inc. is on file with us.
Keep reading
More on Resmed Inc. and the records around it.
Resmed Inc. elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- AustralianSuper Pty Ltd also filed stake reports on 2 other companies: QXO, Inc. (Aug 2025)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/resmed